Patents
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
03/2007
03/07/2007CN1923998A Static culture technology of cordycep liquid
03/07/2007CN1923997A Lyophyllum decastes edible fungus spawn
03/07/2007CN1923996A Apirulina containing spirulina bioactive peptide and spirulina proteinase, preparation method and application thereof
03/07/2007CN1923995A Culture method of dunalilla salina
03/07/2007CN1923994A Culture method of dunalilla salina
03/07/2007CN1923993A Novel method of effective separating manifold micro algae germplasm
03/07/2007CN1923850A Control gene of paddy leaf shape and application thereof
03/07/2007CN1923720A Method of consolidating heavy metal ion by microorganism
03/07/2007CN1303214C Isolated luciferases and use thereof
03/07/2007CN1303213C Promoters and usage thereof
03/07/2007CN1303212C Non-structural protein gene NS1 of avian influenza virus and its preparation method and use
03/07/2007CN1303202C Ethanol feedback control flow added high density fermentation method for yeast and use thereof
03/06/2007US7186893 Nucleotide sequences coding insecticidal protein for generation and propagation of insect and disease resistant corn and potatoes; biological pest control
03/06/2007US7186887 For increase the drought tolerance of plants; gene expression inhibition
03/06/2007US7186820 Antibody for use in the treatment of rheumatic and osteoarthritis
03/06/2007US7186817 Comprises hydrolase for degradation of phytate and increased digestibility and nutrient quality of plants and animal feeds
03/06/2007US7186816 Photolyase nucleic acids
03/06/2007US7186815 Method of isolating secretion signals in lactic acid bacteria and novel secretion signals isolated from Lactococcus lactis
03/06/2007US7186810 Modified peptides as therapeutic agents
03/06/2007US7186805 Fusion proteins; for inhibition of cognate receptor
03/06/2007US7186803 Human vanilloid receptor VR3 protein
03/06/2007US7186802 Membrane proteins; for treatment of inflammation, asthma, allergy, metastasis of cancer cells, ion transport disorders such as magnesium defects in the kidney, and inflammatory bowel disease
03/06/2007US7186800 Fc domains of immunoglobulins; fas genes/proteins; drug screening
03/06/2007US7186545 Probiotic strains from Lactobacillus salivarius and antimicrobial agents obtained therefrom
03/06/2007US7186541 3-hydroxypropionic acid and other organic compounds
03/06/2007US7186540 Thermostable glutaminase and thermostable glutaminase gene
03/06/2007US7186537 Human GAK-related gene variants associated with lung cancer
03/06/2007US7186536 A genetic engineered protein encoded by a DNA sequence or a hybrids, culturng the transformant cells, drug screening, for developing cell growth inhibitors or antitumor agents
03/06/2007US7186535 To act on reducing partial starch hydrolysates to produce non-reducing saccharides, and collecting the non-reducing saccharides or saccharide
03/06/2007US7186534 Screening for predisposition to cancer, screening for enzyme inhibitors
03/06/2007US7186532 Process for producing D-serine
03/06/2007US7186531 L-threonine producing bacterium belonging to the genus Escherichia and method for producing L-threonine
03/06/2007US7186527 Goodpasture antigen binding protein
03/06/2007US7186526 Useful in effecting accelerated healing of wounds, bone fractures, burn tissue, damaged myocardial tissue, degenerated neurological tissue, or other trauma
03/06/2007US7186525 Providing a cell-free system comprising a bacterial cell-free extract; adding a DNA template comprising a bacterial promoter with at least one UP element to said cell free system; recovering the synthesized RNA
03/06/2007US7186524 Preparing transgenic vectors capable of transformation, propagation and expression of cell surface ligand binding activity in host cells; drug screening
03/06/2007US7186523 Providing a Rhodococcus host cell which comprises gamma -carotene;transforming the host cell of with a gene encoding a polypeptide, growing the transformed host cell of under conditions whereby an aryl carotenoid is produced
03/06/2007US7186511 Oxidase
03/06/2007US7186503 Compounds and methods for modulating activation of NF-κB
03/06/2007US7186502 Process for preparing control samples of particles such as microorganisms and cells
03/06/2007US7186428 Method of oxygenating yeast slurry using hydrophobic polymer membranes
03/06/2007US7186411 Vaccines absorbable by the transmucosal way
03/06/2007CA2240393C Method for producing temperature-tolerant plants
03/01/2007WO2007025145A2 Method, apparatus and system for biodiesel production from algae
03/01/2007WO2007024997A2 Methods of increasing production of secondary metabolites
03/01/2007WO2007024718A2 Genetically modified host cells and use of same for producing isoprenoid compounds
03/01/2007WO2007024516A2 Stabilized actively aerated compost tea
03/01/2007WO2007024255A1 Process for the treatment of methane emissions
03/01/2007WO2007024011A1 L-glutamic acid-producing bacterium and method for production of l-glutamic acid
03/01/2007WO2007024010A1 L-glutamic acid-producing bacterium and method for production of l-glutamic acid
03/01/2007WO2007023930A1 Brain-migrating cell and use thereof
03/01/2007WO2007023912A1 Bifidobacterium having effect of inhibiting the adhesion of pathogenic microbes to cells, processed product thereof and food and medicinal composition containing the same
03/01/2007WO2007023711A1 Microbe culturing apparatus, incubator and culturing method
03/01/2007WO2007023628A1 Secretory antigen 1 protein of babesia gibsoni, dna encoding the same and use thereof
03/01/2007WO2007023588A1 Additive for livestock feeds
03/01/2007WO2007022623A1 Regulation of heterologous recombinant protein expression in methylotrophic and methanotrophic bacteria
03/01/2007WO2007008370A3 Stabilized liquid yeast preparation and method for producing the same, and thereof
03/01/2007WO2006085954A3 In vitro reconstitution of ribonucleoprotein complexes, and methods of use therefor
03/01/2007WO2006083240A3 Microbially expressed xylanases and their use as feed additives and other uses
03/01/2007WO2006066147A3 Ambruticin vs compounds
03/01/2007WO2004046343A3 Polynucleotide sequence detection assays and analysis
03/01/2007WO2003086277A3 Attenuated gram negative bacteria
03/01/2007US20070050865 Polynucleotide encoding 2-hydorxyisoflavanone dehydratase and application of the same
03/01/2007US20070049736 Cytokine receptor specific immunoglobulin for prevention and treatment of infection, cell proliferative and autoimmune disorders
03/01/2007US20070049532 Selecting by phage display a peptide that binds to nerve growth factor (NGF), and preparing a fusion protein with an Fc domain; biological half-life increases
03/01/2007US20070048854 Obtained from Campylobacter species; for use in synthesis of lipooligosaccharide (LOS); ganglioside biosynthesis and mimetics for treatment of nervous system disorders
03/01/2007US20070048852 Directed selective solid-phase culturing of stable microbial mixed populations for the continuous preparation of defined enzyme and metabolite mixtures
03/01/2007US20070048851 Method for sustained microbial production of hydrogen gas in a bioreactor using klebsiella oxytoca
03/01/2007US20070048850 System for sustained microbial production of hydrogen gas in a bioreactor using klebsiella oxytoca
03/01/2007US20070048849 Contacting glycerol or 1,3-dihydroxyacetone with a single recombinant yeast or filamentous fungi expressing an exogenous glycerol dehydratase enzyme from Klebsiella or Citrobacter; fermentation
03/01/2007US20070048848 Method, apparatus and system for biodiesel production from algae
03/01/2007US20070048846 Detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells
03/01/2007US20070048842 using an E. coli expression system for the large scale production of IL-21 to a level of greater than 1 g/L in fed batch fermentation
03/01/2007US20070048841 Viricidal polypeptide for prevention and treatment of hepatitis infection
03/01/2007US20070048840 Human Zven polynucleotides
03/01/2007US20070048839 Novel amylolytic enzyme extracted from bacillus sp. A 7-7 (DSM 12368) and washing and cleaning agents containing this novel amylolytic enzyme
03/01/2007US20070048838 Peptide-forming enzyme gene, peptide-forming enzyme, and peptide producing method
03/01/2007US20070048828 Comprises fusion protein comprising platelet derived growth factor for treating connective tissue, tumor and bone disorders; used to stimulate the production of bone and/or connective tissue in both humans and non-human animals
03/01/2007US20070048825 Compositions and methods for the diagnosis and treatment of tumor
03/01/2007US20070048823 Compositions and Methods for Producing Apolipoprotein Gene Products in Lactic Acid Bacteria
03/01/2007US20070048817 Synthesiing a cyclic dipeptide (Albonoursin) by transforming a host cell with a vector having a specific sequence and incubating to allow expression of a cyclodipeptide synthase that subsequently catalizes the cyclization of two amino acids
03/01/2007US20070048804 Methods of detecting cytokine receptor zcytor19 ligand
03/01/2007US20070048799 hematopoietic cytokine receptor polypeptide encoded by nucleotides equences for use in the treatment of cancer; restoring normal blood cell levels in patients suffering from anemia, thrombocytopenia, and neutropenia or receiving chemotherapy for cancer; biodrugs
03/01/2007US20070048773 Detection of polyphosphate using fluorescently labeled polyphosphate acceptor substrates
03/01/2007US20070048748 Mutant polymerases for sequencing and genotyping
03/01/2007US20070048331 Non-toxic mutants of pathogenic gram-negative bacteria
03/01/2007US20070048311 ANTI-INTERFERON-alpha ANTIBODIES
03/01/2007US20070048286 Method of treating dopaminergic and GABA-nergic disorders
03/01/2007US20070048256 Expression vector comprising nucleotide sequences coding cytokine protein for diagnosis, prevention and treatment of thymus disorders
03/01/2007US20070044681 Method for manufacturing monascus pigment
03/01/2007CA2620934A1 Compositions and methods for determining protein interactions using tat signal sequence and marker protein
03/01/2007CA2620420A1 Translation enhancer-element dependent vector systems
03/01/2007CA2619989A1 Regulation of heterologous recombinant protein expression in methylotrophic and methanotrophic bacteria
03/01/2007CA2619943A1 Compositions and methods for producing apolipoprotein gene products in lactic acid bacteria
03/01/2007CA2619833A1 Use of crispr associated genes (cas)
03/01/2007CA2618727A1 Stabilized actively aerated compost tea
02/2007
02/28/2007EP1757697A2 Group B streptococcus antigens
02/28/2007EP1757696A2 Group B streptococcus proteins, and their use
02/28/2007EP1757690A1 Gene encoding guanine nucleotide exchange factor and its gene product
02/28/2007EP1757685A1 Modified ethylenediamine-n,n' disuccinic acid:ethylenediamine lyase